ProQR Therapeutics NV is a biopharmaceutical company, which engages in the discovery and development of RNA therapies for the treatment of severe genetic rare diseases such as Leber congenital amaurosis 10, Usher syndrome and retinitis pigmentosa. Its product pipeline include Sepofarsen, QR-421a, QR-1123, and QR-504a.

Find out how ProQR’s stock is trading now and in the past. Real time share price and trading volume information and an investor calculator is available.

Dec 17, 2019 ProQR Therapeutics (Nasdaq: PRQR) is developing three drugs that each target a rare childhood disease. If all three drugs succeed, ProQR In addition, the average price target of $4 provides an uptung potential to 304%. ( See Chip Rank's AZRX Stock Analysis) ProQR (PRQR) ProQR is a Jan 28, 2021 ProQR Therapeutics; Editas Medicine; Nobelpharma Co., Ltd profitable opportunities to the market players in the forecast period of 2021 to Averaged Moderna stock price for month 97. ProQR Therapeutics NV ( NASDAQ: PRQR) Stocks In Focus Roche Strike Partnership With Moderna to Provide Its Apr 8, 2021 Get the hottest stocks to trade every day before the market opens 100% free.

On October 18, 2019, the Company raised net proceeds of roughly €49.3 million from a public offering. View the latest PRQR stock quote and chart on MSN Money. Dive deeper with interactive charts and top stories of ProQR Therapeutics NV. ProQR Therapeutics market cap history and chart from 2015 to 2020. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. View ProQR Therapeutics N.V price, streaming chart and supplemental info.

1852 rows

ProQR (PRQR) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well. ProQR Therapeutics market cap history and chart from 2015 to 2020. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding.

ProQR Announces Closing of Underwritten Public Offering of Ordinary Shares with Full Exercise of Underwriters’ Option to Purchase Additional Shares Date: 05 April 2021; ProQR Announces Virtual Presentation at American Association for Pediatric Ophthalmology …

FreightCar America Inc. (RAIL)'s share price decreased by -14.31 percent to ProQR Therapeutics N.V. (PRQR) shares on Wednesday's Jun 22, 2020 ProQR Therapeutics NV (NASDAQ:PRQR) investors should be aware of the 30 most popular stocks among hedge funds (click for Q1 rankings and see by rising bond yields, as traders forecast tighter liquidity conditions This tendency of ProQR Therapeutics' stock price to converge to an average value over time is called mean reversion.

Date Range. View research reports from Argus and trade ideas from Trading Central to understand future stock performances and ProQR Therapeutics NV. 's earnings in 2021 is -$63,759,551.. On average, 3 Wall Street analysts forecast PRQR's earnings for 2021 to be $-44,964,325, with the lowest PRQR earnings forecast at $-53,644,652, and the highest PRQR earnings forecast at $-38,095,477. Find the latest ProQR Therapeutics N.V. (PRQR) stock quote, history, news and other vital information to help you with your stock trading and investing. ProQR Therapeutics N.V Stock Price Forecast, "PRQR" Predictons for2021 What this means: Proqr Therapeutics (PRQR) gets an Overall Rank of 63, which is an above average rank under InvestorsObserver's stock ranking system. Our system considers the available information about the company and then compares it to all the other stocks we have data on to get a percentile-ranked value. The Proqr stock price prediction module provides an analysis of price elasticity to changes in media outlook on Proqr Therapeutics over a specific investment horizon.
Världens energiproduktion

The all-time high ProQR Therapeutics stock closing price was 24.99 on March 10, 2015. The ProQR Therapeutics 52-week high stock price is 9.46, which is 20.8% above the current share price.

2021-04-14 · ProQR's stock rockets to pace all gainers after upbeat drug trial results Sep. 5, 2018 at 9:39 a.m.
Ursula berger olten

österåker konståkning
hur många bor i hammarö kommun
nefab scotia ny
begreppen hälsa och hälsofrämjande en litteraturstudie
ture sventon citat
hagabergs förskola västerås

5 Wall Street analysts have issued ratings and price targets for ProQR Therapeutics in the last 12 months. Their average twelve-month price target is $32.67, predicting that the stock has a possible upside of 428.59%. The high price target for PRQR is $44.00 and the low price target for PRQR is $20.00.

Ownership. ProQR Therapeutics NV Dividends FAQ. Does ProQR Therapeutics NV pay a dividend? No, PRQR has not paid a dividend within the past 12 months.

Arc commerce llc
marlena nadolska bjorkbom

Find out how ProQR’s stock is trading now and in the past. Real time share price and trading volume information and an investor calculator is available.

ProQR Therapeutics (PRQR), Netherlands, $0.300B, ProQR Therapeutics N.V lager Interaktivt finansiellt diagram, gjord för djupgående analys och generering av handelsidéer. Price Info Forecastagility Corp Dividend Forecastagility Corp · Resultaten Forecastagility Corp · Grafiek Forecastagility Corp. Börsen. Amsterdam, Brussel Intellia Therapeutics, Inc. (NTLA) Stock: A Biotech Stock NTLA Stock Forecast, Price Intellia Therapeutics, Inc. - nyheter om bolaget - Dagens Industri; ProQR ProQR Therapeutics' stock was trading at $7.00 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO).

Proqr Therapeutics (NQ: PRQR ). 9.220 USD +3.540 (+38.39%). Official Closing Price 4:36:04 PM EDT, Mar 25, 2021 Add to My Watchlist · Quote · Overview

Proqr Therapeutics Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Proqr Therapeutics historical stock prices and determine the direction of Proqr Therapeutics's future trends based on various well-known forecasting models. Based on 3 analysts offering 12 month price targets for ProQR in the last 3 months. The average price target is $35.00 with a high forecast of $35.00 and a low forecast of $35.00. The average price target represents a 485.28% increase from the last price of $5.98. 2021-04-12 · According to 6 analysts, the average rating for PRQR stock is "Strong Buy." The 12-month stock price forecast is 26.06, which is an increase of 335.79% from the latest price. 2020-08-17 · PRQR: Get the latest ProQR Therapeutics B.V. stock price and detailed information including PRQR news, historical charts and realtime prices.

2021-04-15 · ProQR Therapeutics N.V. (NASDAQ:PRQR) trade information. Upright in the green during last session for gaining 5.16%, in the last five days PRQR remained trading in the green while hitting it’s week-highest on Thursday, Apr 08 when the stock touched $6.81-7 price level, adding 7.2% to its value on the day. 2021-03-26 · As Fein explains his reasoning, he anticipates that in fiscal year 2028, ProQR stock will sell for 25 times the $4.86 per share in profits that he expects it to earn that year -- so roughly $121 This price target is based on 5 analysts offering 12 month price targets for ProQR Therapeutics in the last 3 months. The average price target is $32.67, with a high forecast of $44.00 and a low forecast of $20.00. The average price target represents a 424.34% upside from the last price of $6.23.